UNSPSC 51393105: Guanabenz acetate

This classification denotes an antihypertensive agent with the molecular formula C8H8Cl2N4.C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 443O19GK1A, chemically known as (2,6-dichlorophenyl)methylideneaminoiminomethanediamine but more generally known as guanabenz acetate, which bears US NIH Compound Identifier 3517. European Medicines Agency schedules Guanabenz acetate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02423MIG.

Most nations, for tariff and trade purposes, schedule guanabenz acetate under HS 29280090 and SITC 51486. As of Q4 2014, GUANABENZ ACETATE remains US FDA's Preferred Term for this commodity. Guanabenz acetate bears US NLM identifiers UMLS ID C0733381 and NCI Concept Code C65826. SMILES: CC(=O)O.C1CC(C(C(C1)CL)/C=N/NC(=N)N)CL.

UNSPSC 51393105 Guanabenz acetate is a Commodity code that does not align with recent state and local procurement activity. The posted opportunities show no purchasing of guanabenz acetate or other pharmaceutical active ingredients. Instead, Seminole County, Florida solicited naloxone and drug deactivation systems through IFB 60459723LAS (due Jul 26, 2023), and the Texas Health and Human Services Commission issued RFI HHS0017013 seeking vendor capabilities for direct-to-manufacturer prescription programs—both acquisitions of finished pharmaceutical products and pharmacy program services, not bulk active pharmaceutical ingredients. The code's nominal scope does not match what is actually being bought under these posted notices.

State and local procurement records show no recent activity for guanabenz acetate as a standalone commodity. The two opportunities tagged or adjacent to this code are misaligned with its pharmaceutical-ingredient classification, suggesting either metadata mislabeling in the source system or no genuine recent demand for this specific ingredient at the state and local level. Without evidence of active solicitation for guanabenz acetate itself, the code presents no clear opportunity signal for vendors in this category.